Biggest News Aggregation in the World
๐Ÿ“ฐ Looking Statement News

Page 60 - Looking Statement News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Looking Statement. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Merck Announces That Joseph Romanelli Will Lead Merck Human Health International, Effective August 1, 2022

20.04.2022 - Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Joseph Romanelli will lead Human Health International, and join Merckโ€™s Executive Team, effective August 1, 2022. He will report directly to Robert M. Davis, ...
United States Master In Business Administration University Of Delaware Statement Of Merck Co Inc Merck Co Inc Exchange Commission

Merck Announces That Joseph Romanelli Will Lead Merck Human Health International, Effective

KENILWORTH, N.J.-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Joseph Romanelli will lead Human Health International, and join Merckโ€™s Executive Team, effective August 1, 2022. He will report directly to Robert M. Davis, chief executive officer and president, Merck.
United States Arpa Garay Jannie Oosthuizen Robertm Davis Joseph Romanelli Merck Executive Team

Lysogene Enters into an Exclusive Worldwide License Agreement with Yeda, the Commercial Arm of the Weizmann Institute of Science, for a Novel Gene Therapy Candidate for Neuronopathic Gaucher Disease and Parkinson Disease with GBA1 Mutations

Lysogene exercises its option after a conclusive research collaboration period Regulatory News: Lysogene (FR0013233475 LYS) (Paris:LYS), a phase 3 gene therapy platform Company targeting central
France General Anthony Futerman Pralph Laufer Yeda Research Development Co Ltd Weizmann Institute Of Science

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science